TOG
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Obstetrician & Gynaecologist 2004;6:2:93-97
doi: 10.1576/toag.6.2.93.26984
Copyright © 2004 by the Royal College of Obstetricians and Gynaecologists.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duncan, I. D
Right arrow Search for Related Content
PubMed
Right arrow Articles by Duncan, I. D

Screening Review

Cervical screening

Ian D Duncan, FRCOG, Reader and Honorary Consultant Gynaecologist/Oncologist

Maternal and Child Health Sciences, Ninewells Hospital, Dundee, Tayside, DD1 9SY, UK. email: ian.d.duncan{at}tuht.scot.nhs.uk

Since the introduction in the late 1980s of UK cervical screening programmes based on computerised call and recall, mortality from cervical cancer has fallen by one-third and incidence has dropped by two-thirds. Current methods of screening have probably reached the limits of their usefulness. However, encouraging new approaches involving liquid-based cytology and automation are in the advanced stages of development. Roles are also being researched for entirely different technologies, including human papillomavirus testing. It is anticipated that both sensitivity and specificity will improve.

Keywords Keywords / cancer / cervix / cytology / papillomavirus / screening







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Royal College of Obstetricians and Gynaecologists.